Vivos Therapeutics, Inc.

VVOS ·Healthcare, Medical Devices, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
DEF 14A Sep 29, 2025 DEF 14A
8-K Sep 18, 2025 8-K
8-K Sep 12, 2025 8-K
424B5 Sep 12, 2025 424B5
EFFECT Sep 10, 2025
CORRESP Sep 8, 2025
S-3/A Sep 5, 2025 S-3/A
8-K/A Aug 25, 2025 8-K/A
8-K Aug 20, 2025 8-K
10-Q Aug 19, 2025 10-Q
NT 10-Q Aug 14, 2025 NT 10-Q
SCHEDULE 13G Jul 14, 2025
3 Jun 20, 2025 PRIMARY DOCUMENT
SCHEDULE 13D Jun 16, 2025
8-K Jun 13, 2025 8-K
8-K Jun 6, 2025 8-K
8-K May 23, 2025 8-K
8-K May 15, 2025 8-K
10-Q May 15, 2025 10-Q
8-K Apr 17, 2025
8-K Mar 31, 2025
10-K Mar 31, 2025
424B5 Feb 14, 2025
8-K Feb 14, 2025
UPLOAD Feb 13, 2025
← Newer Page 3 of 12 · 287 filings Older →